会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明专利
    • Glycerol derivative, preparation thereof and drug containing said derivative
    • 甘氨酸衍生物,其制剂和含有所述衍生物的药物
    • JPS5931738A
    • 1984-02-20
    • JP14175582
    • 1982-08-17
    • Ono Pharmaceut Co Ltd
    • ARAI YOSHINOBUITOU HIROYUKIMIYAMOTO TSUMORU
    • C07C271/20C07C67/00C07C213/00C07C217/28C07C231/00C07C231/02C07C231/12C07C235/10C07C239/00
    • NEW MATERIAL:A compound of formula I [A is imino or carbonylamino; R
      1 is 8W22C alkyl or 1W5C alkyl substituted by phenyl group; R
      2 is H or group of formula II (R
      5 is H, halogen, OCH
      3 , etc.), and further COR
      6 or CONHR
      6 (R
      6 is alkyl or phenyl) when A is carbonylamino; R
      3 is alkylene; R
      4 is amino, NHCOR
      7 (R
      7 is R
      6 ), etc.] or an acid addition salt thereof.
      EXAMPLE: (2RS)-1-O-hexadecyl-2-O-benzyl-3-[ 4-(N, N-dimethylamino)butylamino ]- 1,2-propanediol.
      USE: An inhibitor for blood platelet agglutination, antiasthmatic agent, antiallergic agent, anti-inflammatory agent, hypotensive agent and antitumor agent.
      PROCESS: A compound of formula III (R
      9 is alkyl- or arylsulfonyl) is reacted with a compound of formula IV to give the corresponding compound of formula I .
      COPYRIGHT: (C)1984,JPO&Japio
    • 新材料:式I化合物[A为亚氨基或羰基氨基; R 1是8-22个碳原子的烷基或1-5个被苯基取代的烷基; R 2是H或式II的基团(R 5是H,卤素,OCH 3等),并且当A(R 5)是C 1 -C 4烷基或苯基时,R 6或CONHR 6 是羰基氨基; R 3是亚烷基; R 4为氨基,NHCOR 7(R 7为R 6)等]或其酸加成盐。 实施例:(2RS)-1-O-十六烷基-2-O-苄基-3- [4-(N,N-二甲基氨基)丁基氨基] -1,2-丙二醇。 用途:血小板凝集抑制剂,止喘药,抗过敏药,抗炎剂,降血压药和抗肿瘤剂。 方法:将式III化合物(R 9是烷基 - 或芳基磺酰基)与式IV化合物反应,得到相应的式I化合物。
    • 5. 发明专利
    • Novel glycerol derivative, its preparation and pharmaceutical containing said derivative
    • 新型甘油衍生物,其制备和药物含有衍生物
    • JPS58198445A
    • 1983-11-18
    • JP7917982
    • 1982-05-13
    • Ono Pharmaceut Co Ltd
    • ITOU HIROYUKIOKADA TADANORIMIYAMOTO TSUMORU
    • A61K31/215A61K31/16A61K31/165A61K31/22A61P7/02A61P29/00C07C67/00C07C209/00C07C209/08C07C209/12C07C209/62C07C211/03C07C231/00C07C231/02C07C231/12C07C231/14C07C233/18C07C233/68C07C239/00C07C275/10
    • NEW MATERIAL:The compound of formula I [R
      1 is alkyl; R
      2 is H, acyl, benzoyl or group of formula II (R
      5 is H, halogen, methoxy or alkyl); R
      3 is alkylene; R
      4 is NH
      2 , NHR
      6 (R
      6 is acyl or benzoyl), NHR
      7 (R
      7 is alkyl), N(R
      7 )
      2 , group of formula III (Y is anion of acid) or NHCONHR
      7 ], or its acid addition salt when R
      4 is NH
      2 .
      EXAMPLE: (2RS)-1-O-Hexadecyl-3-O-(4-aminobutyl)glycerol.
      USE: Blood platelet coagulation inhibitor, antiasthmatic agent, antiallergic agent, antiphlogistic agent, hypotensor and antitumor agent.
      PROCESS: The compound of formula I wherein R
      2 is group of fomrula II and R
      4 is NHR
      7 , N(R
      7 )
      2 or group of formula III can be prepared by reacting the compound of formula IV (Tr is trityl) with R
      5 -substituted benzyl halide, reacting the resultant compound of formula V with the compound of formula R
      10 -O-R
      3 - Cl to obtain the compound of formula VI, and finally reacting the product with the compound of formula NH
      2 R
      7 , NH(R
      7 )
      2 or N(R
      7 )
      3 .
      COPYRIGHT: (C)1983,JPO&Japio
    • 新材料:式I化合物[R 1]是烷基; R 2是H,酰基,苯甲酰基或式II的基团(R 5是H,卤素,甲氧基或烷基); R 3是亚烷基; R 4是NH 2,NHR 6(R 6是酰基或苯甲酰基),NHR 7(R 7是烷基),N(R 7)2,式III(Y 是酸的阴离子)或NHCONHR 7]或其酸加成盐,当R 4是NH 2时。 实施例:(2RS)-1-O-十六烷基-3-O-(4-氨基丁基)甘油。 用途:血小板凝固抑制剂,止喘药,抗过敏药,消炎药,低血压药和抗肿瘤药。 方法:其中R 2是式II和R 4的基团的式I化合物是NHR 7,N(R 7)2或式III的基团可以通过使式 IV(Tr是三苯甲基)与R 5取代的苄基卤反应,使得到的式V化合物与式R 10 -OR 3 Cl的化合物反应,得到式VI化合物,最后使 具有式NH 2 R 7,NH(R 7)2或N(R 7)3的化合物的产物。